29 August 2008
Comparison of fluorescent in situ hybridization and histological method for the diagnosis of Helicobacter pylori in gastric biopsy samplesSaeed TajbakhshABCDEFG, Ali Reza Samarbaf-ZadehAFG, Mojtaba MoosavianCF
Med Sci Monit 2008; 14(9): BR183-187 :: ID: 867956
The establishment of Helicobacter pylori in the stomach and duodenum is associated with gastritis, peptic ulcers, and gastric cancer. Application of suitable methods, including molecular techniques, for an accurate detection of H. pylori can lead to the administration of appropriate drugs and successful therapy. In this study, fluorescent in situ hybridization (FISH) was compared with histology for the diagnosis of H. pylori in gastric biopsy specimens.
Material and Method
Flourescently labeled oligonucleotdie probes that target ribosomal RNA were utilized in the FISH procedure. Ninety-one gastric biopsy specimens were tested by FISH and by histology using hematoxylin-eosin (H-E) and Geimsa stains. Furthermore, clarithromycin resistance in 39 of the 91 specimens was examined by FISH.
The sensitivity and specificity of FISH for the detection of H. pylori were 97.9% and 100%, respectively. Of the 39 samples that were tested for clarithromycin resistance, 19 were FISH positive for H. pylori, of which 15 and 4 specimens were infected with clarithromycin-susceptible and clarithromycin-resistant strains, respectively. There were coccoid forms of H. pylori in a few of the specimens.
FISH is a highly sensitive and specific technique for the diagnosis of H. pylori infection. It can be a method of identification when a patient is infected with coccoid forms of H. pylori. The ability of FISH for determination of clarithromycin resistance is a considerable advantage of this method over histology.
Keywords: In Situ Hybridization, Fluorescence - utilization, Histocytochemistry - methods, Helicobacter pylori - metabolism, Helicobacter Infections - drug therapy, Gastric Mucosa - pathology, Drug Resistance, Bacterial, Sensitivity and Specificity, Clarithromycin - therapeutic use, Biopsy, Anti-Bacterial Agents - therapeutic use
04 June 2022 : EditorialEditorial: Acute Hepatitis of Unknown Origin in Children. Is Autoimmunity at Play?
Med Sci Monit 2022; 28:e937371
27 June 2022 : Clinical ResearchShoulder Injury Related to Vaccine Administration (SIRVA) in 16 Patients Following COVID-19 Vaccination Who...
Med Sci Monit In Press; DOI: 10.12659/MSM.937430
04 June 2022 : Clinical ResearchScreening for SARS-CoV-2 Infection in Students at the Medical University of Warsaw, Poland Between November...
Med Sci Monit 2022; 28:e936962
30 May 2022 : Clinical ResearchEffects of Wearing Face Masks on Exercise Capacity and Ventilatory Anaerobic Threshold in Healthy Subjects ...
Med Sci Monit 2022; 28:e936069
28 Jun 2022 : Meta-AnalysisUrodynamics in Early Diagnosis of Diabetic Bladder Dysfunction in Women: A Systematic Review and Meta-Analysis
Med Sci Monit In Press; DOI: 10.12659/MSM.937166
28 Jun 2022 : Clinical ResearchSerum Calprotectin – a NET Product – as a Biomarker of Disease Activity in Patients with Systemic Lupus Ery...
Med Sci Monit In Press; DOI: 10.12659/MSM.936534
28 Jun 2022 : Database AnalysisLINC00963 May Be Associated with a Poor Prognosis in Patients with Cervical Cancer
Med Sci Monit In Press; DOI: 10.12659/MSM.935070
Most Viewed Current Articles
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Nov 2020 : Review articleLong-Term Respiratory and Neurological Sequelae of COVID-19
Med Sci Monit 2020; 26:e928996